Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.

Levin J, Maaß S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Südmeyer M, Eggert K, Mollenhauer B, Lipp A, Löhle M, Classen J, Münchau A, Kassubek J, Gandor F, Berg D, Egert-Schwender S, Eberhardt C, Paul F, Bötzel K, Ertl-Wagner B, Huppertz HJ, Ricard I, Höglinger GU; PROMESA Study Group.

Lancet Neurol. 2019 Aug;18(8):724-735. doi: 10.1016/S1474-4422(19)30141-3. Epub 2019 Jul 2.

PMID:
31278067
2.

Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study.

Zimmermann J, Jesse S, Kassubek J, Pinkhardt E, Ludolph AC.

J Neurol. 2019 Jun 27. doi: 10.1007/s00415-019-09387-w. [Epub ahead of print]

PMID:
31250103
3.

Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study.

Gorges M, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R; LANDSCAPE Consortium, Hilker-Roggendorf R, Berg D, Kunz MS, Kalbe E, Baudrexel S, Kassubek J.

Ther Adv Neurol Disord. 2019 May 16;12:1756286419843447. doi: 10.1177/1756286419843447. eCollection 2019.

4.

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis.

Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M.

Sci Rep. 2019 Jun 5;9(1):8433. doi: 10.1038/s41598-019-43990-1.

5.

10Kin1day: A Bottom-Up Neuroimaging Initiative.

van den Heuvel MP, Scholtens LH, van der Burgh HK, Agosta F, Alloza C, Arango C, Auyeung B, Baron-Cohen S, Basaia S, Benders MJNL, Beyer F, Booij L, Braun KPJ, Filho GB, Cahn W, Cannon DM, Chaim-Avancini TM, Chan SSM, Chen EYH, Crespo-Facorro B, Crone EA, Dannlowski U, de Zwarte SMC, Dietsche B, Donohoe G, Plessis SD, Durston S, Díaz-Caneja CM, Díaz-Zuluaga AM, Emsley R, Filippi M, Frodl T, Gorges M, Graff B, Grotegerd D, Gąsecki D, Hall JM, Holleran L, Holt R, Hopman HJ, Jansen A, Janssen J, Jodzio K, Jäncke L, Kaleda VG, Kassubek J, Masouleh SK, Kircher T, Koevoets MGJC, Kostic VS, Krug A, Lawrie SM, Lebedeva IS, Lee EHM, Lett TA, Lewis SJG, Liem F, Lombardo MV, Lopez-Jaramillo C, Margulies DS, Markett S, Marques P, Martínez-Zalacaín I, McDonald C, McIntosh AM, McPhilemy G, Meinert SL, Menchón JM, Montag C, Moreira PS, Morgado P, Mothersill DO, Mérillat S, Müller HP, Nabulsi L, Najt P, Narkiewicz K, Naumczyk P, Oranje B, Ortiz-Garcia de la Foz V, Peper JS, Pineda JA, Rasser PE, Redlich R, Repple J, Reuter M, Rosa PGP, Ruigrok ANV, Sabisz A, Schall U, Seedat S, Serpa MH, Skouras S, Soriano-Mas C, Sousa N, Szurowska E, Tomyshev AS, Tordesillas-Gutierrez D, Valk SL, van den Berg LH, van Erp TGM, van Haren NEM, van Leeuwen JMC, Villringer A, Vinkers CH, Vollmar C, Waller L, Walter H, Whalley HC, Witkowska M, Witte AV, Zanetti MV, Zhang R, de Lange SC.

Front Neurol. 2019 May 9;10:425. doi: 10.3389/fneur.2019.00425. eCollection 2019.

6.

Dyskinesia in multiple system atrophy and progressive supranuclear palsy.

Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A.

J Neural Transm (Vienna). 2019 May 13. doi: 10.1007/s00702-019-02012-0. [Epub ahead of print] Review.

PMID:
31087195
7.

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G.

Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

8.

Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder.

Schönfeldt-Lecuona C, Kregel T, Schmidt A, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Gahr M, Pinkhardt EH.

Schizophr Res. 2019 Apr 11. pii: S0920-9964(19)30116-1. doi: 10.1016/j.schres.2019.03.022. [Epub ahead of print]

PMID:
30981598
9.

Editorial: Computerized Magnetic Resonance Imaging-Based Neuroimaging of Neurodegenerative Diseases.

Müller HP, Kassubek J.

Front Neurol. 2019 Mar 15;10:237. doi: 10.3389/fneur.2019.00237. eCollection 2019. No abstract available.

10.

Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging.

Albrecht F, Mueller K, Ballarini T, Lampe L, Diehl-Schmid J, Fassbender K, Fliessbach K, Jahn H, Jech R, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Ludolph AC, Lyros E, Prudlo J, Schneider A, Synofzik M, Wiltfang J, Danek A, Otto M; FTLD-Consortium, Schroeter ML.

Cortex. 2019 Feb 25;117:33-40. doi: 10.1016/j.cortex.2019.02.015. [Epub ahead of print]

11.

Prognostic factors in ALS: a comparison between Germany and China.

Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hübers A, Schuster J, Weishaupt JH, Kassubek J, Gess B, Meyer T, Weyen U, Hermann A, Winkler J, Grehl T, Hagenacker T, Lingor P, Koch JC, Sperfeld A, Petri S, Großkreutz J, Metelmann M, Wolf J, Winkler AS, Klopstock T, Boentert M, Johannesen S, Storch A, Schrank B, Zeller D, Liu XL, Tang L, Fan DS, Ludolph AC.

J Neurol. 2019 Jun;266(6):1516-1525. doi: 10.1007/s00415-019-09290-4. Epub 2019 Mar 28.

PMID:
30923935
12.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Mar 18. doi: 10.1002/mds.27666. [Epub ahead of print]

PMID:
30884545
13.

Shank3 Transgenic and Prenatal Zinc-Deficient Autism Mouse Models Show Convergent and Individual Alterations of Brain Structures in MRI.

Schoen M, Asoglu H, Bauer HF, Müller HP, Abaei A, Sauer AK, Zhang R, Song TJ, Bockmann J, Kassubek J, Rasche V, Grabrucker AM, Boeckers TM.

Front Neural Circuits. 2019 Feb 22;13:6. doi: 10.3389/fncir.2019.00006. eCollection 2019.

14.

Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials.

Müller HP, Huppertz HJ, Dreyhaupt J, Ludolph AC, Tabrizi SJ, Roos RAC, Durr A, Landwehrmeyer GB, Kassubek J.

Parkinsonism Relat Disord. 2019 Feb 5. pii: S1353-8020(19)30035-5. doi: 10.1016/j.parkreldis.2019.02.004. [Epub ahead of print]

PMID:
30846243
15.

Juxtacortical lesions are associated with seizures in cerebral small vessel disease.

Stösser S, Böckler S, Ludolph AC, Kassubek J, Neugebauer H.

J Neurol. 2019 May;266(5):1230-1235. doi: 10.1007/s00415-019-09253-9. Epub 2019 Feb 26.

PMID:
30806767
16.

A biallelic mutation links MYORG to autosomal-recessive primary familial brain calcification.

Forouhideh Y, Müller K, Ruf W, Assi M, Seker T, Tunca C, Knehr A, Strom TM, Gorges M, Schradt F, Meitinger T, Ludolph AC, Pinkhardt EH, Basak AN, Kassubek J, Uttner I, Weishaupt JH.

Brain. 2019 Feb 1;142(2):e4. doi: 10.1093/brain/awy343. No abstract available.

PMID:
30649222
17.

Two histological methods for recognition and study of cortical microinfarcts in thick sections.

Braak H, Feldengut S, Kassubek J, Yilmazer-Hanke D, Del Tredici K.

Eur J Histochem. 2018 Dec 20;62(4). doi: 10.4081/ejh.2018.2989.

18.

On Razor's edge: Managing analgosedation during severe anti-NMDA receptor encephalitis.

Jesse S, Wagner J, Gastl R, Steinacker P, Otto M, Kassubek J, Lewerenz J.

Neurol Neuroimmunol Neuroinflamm. 2018 Nov 19;6(1):e522. doi: 10.1212/NXI.0000000000000522. eCollection 2019 Jan. No abstract available.

19.

The applause sign in frontotemporal lobar degeneration and related conditions.

Schönecker S, Hell F, Bötzel K, Wlasich E, Ackl N, Süßmair C; German FTLD Consortium, Otto M, Anderl-Straub S, Ludolph A, Kassubek J, Huppertz HJ, Diehl-Schmid J, Riedl L, Roßmeier C, Fassbender K, Lyros E, Kornhuber J, Oberstein TJ, Fliessbach K, Schneider A, Schroeter ML, Prudlo J, Lauer M, Jahn H, Levin J, Danek A.

J Neurol. 2019 Feb;266(2):330-338. doi: 10.1007/s00415-018-9134-y. Epub 2018 Dec 1.

PMID:
30506397
20.

Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions.

Forsberg KME, Zhang Y, Reiners J, Ander M, Niedermayer A, Fang L, Neugebauer H, Kassubek J, Katona I, Weis J, Ludolph AC, Del Tredici K, Braak H, Yilmazer-Hanke D.

Acta Neuropathol Commun. 2018 Nov 23;6(1):128. doi: 10.1186/s40478-018-0632-z.

21.

Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis.

Müller HP, Agosta F, Gorges M, Kassubek R, Spinelli EG, Riva N, Ludolph AC, Filippi M, Kassubek J.

Neuroimage Clin. 2018;20:1062-1069. doi: 10.1016/j.nicl.2018.10.005. Epub 2018 Oct 9.

22.

Analysis of CACNA1A CAG repeat lengths in patients with familial ALS.

Brenner D, Müller K, Gastl R, Gorges M, Otto M, Pinkhardt EH, Kassubek J, Weishaupt JH, Ludolph AC.

Neurobiol Aging. 2019 Feb;74:235.e5-235.e8. doi: 10.1016/j.neurobiolaging.2018.09.019. Epub 2018 Sep 22.

PMID:
30342765
23.

Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta-analysis of diffusion tensor imaging data.

Gorges M, Del Tredici K, Dreyhaupt J, Braak H, Ludolph AC, Müller HP, Kassubek J.

Sci Rep. 2018 Oct 18;8(1):15389. doi: 10.1038/s41598-018-33830-z.

24.

MRI-Based Mapping of Cerebral Propagation in Amyotrophic Lateral Sclerosis.

Müller HP, Kassubek J.

Front Neurosci. 2018 Sep 26;12:655. doi: 10.3389/fnins.2018.00655. eCollection 2018.

25.

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.

Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, Tumani H, von Arnim CAF, Dorst J, Feneberg E, Mayer B, Müller HP, Gorges M, Rosenbohm A, Volk AE, Silani V, Ludolph AC, Otto M.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):157-164. doi: 10.1136/jnnp-2018-318704. Epub 2018 Oct 11.

PMID:
30309882
26.

Serum GFAP as a biomarker for disease severity in multiple sclerosis.

Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M.

Sci Rep. 2018 Oct 4;8(1):14798. doi: 10.1038/s41598-018-33158-8. Erratum in: Sci Rep. 2019 Jun 5;9(1):8433.

27.

Serum neurofilament light chain in behavioral variant frontotemporal dementia.

Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, von Arnim CAF, Barthel H, Danek A, Fassbender K, Fliessbach K, Foerstl H, Grimmer T, Huppertz HJ, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Maler JM, Mayer B, Oeckl P, Prudlo J, Schneider A, Volk AE, Wiltfang J, Schroeter ML, Ludolph AC, Otto M; FTLDc study group.

Neurology. 2018 Oct 9;91(15):e1390-e1401. doi: 10.1212/WNL.0000000000006318. Epub 2018 Sep 12.

PMID:
30209235
28.

Targeting head movements in humans: Compensation for disturbance from simultaneous body rotations.

Becker W, Kassubek J, Maurer C, Mergner T.

Hum Mov Sci. 2018 Oct;61:197-218. doi: 10.1016/j.humov.2018.08.007. Epub 2018 Sep 3.

PMID:
30189333
29.

[Botulinum toxin for neurogenic dysphagia after brainstem ischemia : Single injection as a treatment of an esophageal opening disorder].

Schradt F, Stösser S, Hänle M, Kassubek J, Lindner-Pfleghar B, Neugebauer H.

Nervenarzt. 2019 Feb;90(2):191-193. doi: 10.1007/s00115-018-0603-4. German. No abstract available.

PMID:
30171305
30.

Acute DWI Reductions In Patients After Single Epileptic Seizures - More Common Than Assumed.

Hübers A, Thoma K, Schocke M, Fauser S, Ludolph AC, Kassubek J, Pinkhardt EH.

Front Neurol. 2018 Jul 25;9:550. doi: 10.3389/fneur.2018.00550. eCollection 2018.

31.

Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Commisso B, Ding L, Varadi K, Gorges M, Bayer D, Boeckers TM, Ludolph AC, Kassubek J, Müller OJ, Roselli F.

Elife. 2018 Aug 23;7. pii: e36892. doi: 10.7554/eLife.36892.

32.

[Parkinson Disease and Pain - diagnostic and therapeutic approaches to a challenging non-motor symptom].

Buhmann C, Ip CW, Oehlwein C, Tönges L, Wolz M, Reichmann H, Kassubek J.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S48-S58. doi: 10.1055/a-0590-4464. Epub 2018 Jul 17. Review. German.

PMID:
30016807
33.

Response letter: Retinal changes in patients with major depressive disorder - a controlled optical coherence tomography study.

Schönfeldt-Lecuona C, Schmidt A, Kregel T, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Pinkhardt EH, Gahr M.

J Affect Disord. 2018 Oct 15;239:123. doi: 10.1016/j.jad.2018.06.049. Epub 2018 Jun 30. No abstract available.

PMID:
29990659
34.

MRI-based neuroimaging: atypical parkinsonisms and other movement disorders.

Kassubek J.

Curr Opin Neurol. 2018 Aug;31(4):425-430. doi: 10.1097/WCO.0000000000000578. Review.

PMID:
29952835
35.

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.

Ludolph AC, Schuster J, Dorst J, Dupuis L, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Petri S, Meyer T, Grosskreutz J, Schrank B, Boentert M, Emmer A, Hermann A, Zeller D, Prudlo J, Winkler AS, Grehl T, Heneka MT, Wollebæk Johannesen S, Göricke B; RAS-ALS Study Group.

Lancet Neurol. 2018 Aug;17(8):681-688. doi: 10.1016/S1474-4422(18)30176-5. Epub 2018 Jun 19.

PMID:
29934198
36.

Structural and Functional Brain Mapping Correlates of Impaired Eye Movement Control in Parkinsonian Syndromes: A Systems-Based Concept.

Gorges M, Müller HP, Kassubek J.

Front Neurol. 2018 May 7;9:319. doi: 10.3389/fneur.2018.00319. eCollection 2018. Review.

37.

Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study.

Müller HP, Gorges M, Kassubek R, Dorst J, Ludolph AC, Kassubek J.

Neuroimage Clin. 2018 Mar 15;18:762-769. doi: 10.1016/j.nicl.2018.03.018. eCollection 2018.

38.

Alpha-synuclein is present in dental calculus but not altered in Parkinson's disease patients in comparison to controls.

Schmid S, Goldberg-Bockhorn E, Schwarz S, Rotter N, Kassubek J, Del Tredici K, Pinkhardt E, Otto M, Ludolph AC, Oeckl P.

J Neurol. 2018 Jun;265(6):1334-1337. doi: 10.1007/s00415-018-8847-2. Epub 2018 Mar 29.

PMID:
29600388
39.

Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients - An Atlas-Based Volumetric MRI Study.

Schönecker S, Neuhofer C, Otto M, Ludolph A, Kassubek J, Landwehrmeyer B, Anderl-Straub S, Semler E, Diehl-Schmid J, Prix C, Vollmar C, Fortea J; Deutsches FTLD-Konsortium, Huppertz HJ, Arzberger T, Edbauer D, Feddersen B, Dieterich M, Schroeter ML, Volk AE, Fließbach K, Schneider A, Kornhuber J, Maler M, Prudlo J, Jahn H, Boeckh-Behrens T, Danek A, Klopstock T, Levin J.

Front Aging Neurosci. 2018 Mar 15;10:45. doi: 10.3389/fnagi.2018.00045. eCollection 2018.

40.

Longitudinal Diffusion Tensor Imaging Resembles Patterns of Pathology Progression in Behavioral Variant Frontotemporal Dementia (bvFTD).

Kassubek J, Müller HP, Del Tredici K, Hornberger M, Schroeter ML, Müller K, Anderl-Straub S, Uttner I, Grossman M, Braak H, Hodges JR, Piguet O, Otto M, Ludolph AC.

Front Aging Neurosci. 2018 Mar 6;10:47. doi: 10.3389/fnagi.2018.00047. eCollection 2018.

41.

Ventral Striatal D2/3 Receptor Availability Is Associated with Impulsive Choice Behavior As Well As Limbic Corticostriatal Connectivity.

Barlow RL, Gorges M, Wearn A, Niessen HG, Kassubek J, Dalley JW, Pekcec A.

Int J Neuropsychopharmacol. 2018 Jul 1;21(7):705-715. doi: 10.1093/ijnp/pyy030.

42.

Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis.

Lulé D, Böhm S, Müller HP, Aho-Özhan H, Keller J, Gorges M, Loose M, Weishaupt JH, Uttner I, Pinkhardt E, Kassubek J, Del Tredici K, Braak H, Abrahams S, Ludolph AC.

Cortex. 2018 Apr;101:163-171. doi: 10.1016/j.cortex.2018.01.004. Epub 2018 Jan 31.

PMID:
29477906
43.

The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.

Rosenbohm A, Hirsch S, Volk AE, Grehl T, Grosskreutz J, Hanisch F, Herrmann A, Kollewe K, Kress W, Meyer T, Petri S, Prudlo J, Wessig C, Müller HP, Dreyhaupt J, Weishaupt J, Kubisch C, Kassubek J, Weydt P, Ludolph AC.

J Neurol. 2018 May;265(5):1026-1036. doi: 10.1007/s00415-018-8790-2. Epub 2018 Feb 20.

PMID:
29464380
44.

In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis.

Abdelhak A, Hübers A, Böhm K, Ludolph AC, Kassubek J, Pinkhardt EH.

J Neurol. 2018 Apr;265(4):949-953. doi: 10.1007/s00415-018-8787-x. Epub 2018 Feb 20.

PMID:
29464376
45.

Dietary pattern associated with selenoprotein P and MRI-derived body fat volumes, liver signal intensity, and metabolic disorders.

di Giuseppe R, Plachta-Danielzik S, Koch M, Nöthlings U, Schlesinger S, Borggrefe J, Both M, Müller HP, Kassubek J, Jacobs G, Lieb W.

Eur J Nutr. 2019 Apr;58(3):1067-1079. doi: 10.1007/s00394-018-1624-2. Epub 2018 Feb 14.

PMID:
29445913
46.

Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Rosenbohm A, Liu M, Nagel G, Peter RS, Cui B, Li X, Kassubek J, Rothenbacher D, Lulé D, Cui L, Ludolph AC; ALS Registry Swabia Study Group.

J Neurol. 2018 Apr;265(4):774-782. doi: 10.1007/s00415-018-8735-9. Epub 2018 Feb 1.

PMID:
29392461
47.

Hyperconnective and hypoconnective cortical and subcortical functional networks in multiple system atrophy.

Rosskopf J, Gorges M, Müller HP, Pinkhardt EH, Ludolph AC, Kassubek J.

Parkinsonism Relat Disord. 2018 Apr;49:75-80. doi: 10.1016/j.parkreldis.2018.01.012. Epub 2018 Jan 12.

PMID:
29352721
48.

Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis.

Baldaranov D, Khomenko A, Kobor I, Bogdahn U, Gorges M, Kassubek J, Müller HP.

Front Hum Neurosci. 2017 Dec 5;11:567. doi: 10.3389/fnhum.2017.00567. eCollection 2017.

49.

Retinal changes in patients with major depressive disorder - A controlled optical coherence tomography study.

Schönfeldt-Lecuona C, Schmidt A, Kregel T, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Pinkhardt EH, Gahr M.

J Affect Disord. 2018 Feb;227:665-671. doi: 10.1016/j.jad.2017.11.077. Epub 2017 Nov 16.

PMID:
29174740
50.

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.

Steinacker P, Verde F, Fang L, Feneberg E, Oeckl P, Roeber S, Anderl-Straub S, Danek A, Diehl-Schmid J, Fassbender K, Fliessbach K, Foerstl H, Giese A, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer GB, Lauer M, Pinkhardt EH, Prudlo J, Rosenbohm A, Schneider A, Schroeter ML, Tumani H, von Arnim CAF, Weishaupt J, Weydt P, Ludolph AC, Yilmazer Hanke D, Otto M; FTLDc study group.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):239-247. doi: 10.1136/jnnp-2017-317138. Epub 2017 Nov 15.

PMID:
29142138

Supplemental Content

Loading ...
Support Center